CompuGroup Medical stock analysis
CompuGroup Medical (0MSD) Share Price & Analysis
0MSD Stock Chart & Stats
- Day’s Range
- EUR 28.40 - EUR 29.30
- 52-Week Range
- EUR 23.60 - EUR 29.45
- Previous Close
- EUR 29.15
- Volume
- N/A
- Average Volume (3M)
- 119
- Market Cap
- EUR 1.50B
- Enterprise Value
- EUR 1.94B
- Total Cash (Recent Filing)
- EUR 128.64M
- Total Debt (Recent Filing)
- EUR 826.65M
- Price to Earnings (P/E)
- 43.4
- Beta
- 0.01
- Next Earnings
- N/A
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Apr 20, 2026
- Dividend Yield
- 1.76%
Bulls Say, Bears Say
Bulls Say
Recurring SaaS And Diversified Revenue Streams
A mixed model of one‑time license sales plus subscription and cloud SaaS creates recurring revenue and higher customer lifetime value. This durability improves predictability, supports retention and upsell, and underpins multi‑year cash flow visibility for reinvestment and debt servicing.
Strong Free Cash Flow And Improving Operating Cash Flow
Consistent positive free cash flow and operating cash generation above net income show strong cash conversion. Over months this supports capital expenditure funding, deleveraging, M&A optionality and shareholder returns without relying on equity raises, enhancing financial resilience.
Operational Efficiency With Solid EBIT/EBITDA Margins
Sustained healthy EBIT/EBITDA margins indicate scalable software economics and disciplined cost control. Margin durability allows the company to reinvest in product development and sales, absorb competitive pricing, and convert revenue growth into stable operating profit over multiple quarters.
Bears Say
Moderate Leverage And Reliance On Debt Financing
A moderate debt load reduces financial flexibility and raises sensitivity to interest costs and refinancing cycles. Over a multi‑month horizon this can constrain strategic moves, limit opportunistic M&A, and force prioritization of cash to debt service rather than growth or shareholder distributions.
Relatively Low Net Profit Margins
Lower net margins mean operational efficiency isn't fully translating to shareholder returns, leaving less buffer for shocks or investment. Persistently weak net profitability can depress returns on equity and limit retained earnings available for strategic initiatives over the coming quarters.
Limited Investor Communication And Event Disclosure
Absence of earnings calls and notable corporate events reduces transparency into strategy execution and management priorities. Over several months this limits investors' ability to assess guidance, hold management accountable, and increases information risk around operational or strategic shifts.
CompuGroup Medical News
0MSD FAQ
What was CompuGroup Medical’s price range in the past 12 months?
What is CompuGroup Medical’s market cap?
When is CompuGroup Medical’s upcoming earnings report date?
How were CompuGroup Medical’s earnings last quarter?
Is CompuGroup Medical overvalued?
Does CompuGroup Medical pay dividends?
What is CompuGroup Medical’s EPS estimate?
How many shares outstanding does CompuGroup Medical have?
What happened to CompuGroup Medical’s price movement after its last earnings report?
Which hedge fund is a major shareholder of CompuGroup Medical?
What is the TipRanks Smart Score and how is it calculated?
CompuGroup Medical Stock Smart Score
Company Description
CompuGroup Medical
CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS). The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions. The PCS segment provides administrative and billing-related software applications for pharmacies. Its software solution provides information and decision support to manage various aspects of supply chain for medication. The HIS segment provides clinical and administrative solutions for the inpatient sector. This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories. The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps. This segment also offers security solutions for healthcare providers. It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers. The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020. CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.
- Sector
- General
- Industry
- Medical - Healthcare Information Services
- CEO
- Daniel Gotthardt
- Employees
- 8,299
- Website
- www.cgm.com
- Address
- Maria Trost 21, Koblenz, 56070, DE
CompuGroup Medical (0MSD) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 11 | 5 | 6 |
| Technical Analysis | 4 | 5 | 1 |
| Moving Averages | 7 | 0 | 5 |
